9th Immunotherapy of Cancer conference (ITOC): A meeting report

The Immunotherapy of Cancer conference (ITOC) is an European meeting providing a global platform for discussions where all those dedicated to the immunotherapy of cancer can exchange their knowledge and the latest findings about immuno-oncology. The 9th ITOC was held in Munich in September 2022. Maj...

Descripción completa

Detalles Bibliográficos
Autores principales: Dalloul, Iman, Strzalkowski, Thaddäus Jan Clemens, von Bergwelt-Baildon, Michael, Nüssler, Volkmar, Zielinski, Christoph, Kobold, Sebastian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Immunotherapeutics – Meeting Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9891670/
https://www.ncbi.nlm.nih.gov/pubmed/36576266
http://dx.doi.org/10.1080/21645515.2022.2159706
_version_ 1784881179785166848
author Dalloul, Iman
Strzalkowski, Thaddäus Jan Clemens
von Bergwelt-Baildon, Michael
Nüssler, Volkmar
Zielinski, Christoph
Kobold, Sebastian
author_facet Dalloul, Iman
Strzalkowski, Thaddäus Jan Clemens
von Bergwelt-Baildon, Michael
Nüssler, Volkmar
Zielinski, Christoph
Kobold, Sebastian
author_sort Dalloul, Iman
collection PubMed
description The Immunotherapy of Cancer conference (ITOC) is an European meeting providing a global platform for discussions where all those dedicated to the immunotherapy of cancer can exchange their knowledge and the latest findings about immuno-oncology. The 9th ITOC was held in Munich in September 2022. Major highlights of the 2022 edition included the key note address and life time achievement to Laurence Zitvogel on her contributions on the understanding of the role of microbiota in cancer development and therapy resistance. Her research has paved the way for therapeutic exploitation of the microbiome.
format Online
Article
Text
id pubmed-9891670
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-98916702023-02-02 9th Immunotherapy of Cancer conference (ITOC): A meeting report Dalloul, Iman Strzalkowski, Thaddäus Jan Clemens von Bergwelt-Baildon, Michael Nüssler, Volkmar Zielinski, Christoph Kobold, Sebastian Hum Vaccin Immunother Immunotherapeutics – Meeting Report The Immunotherapy of Cancer conference (ITOC) is an European meeting providing a global platform for discussions where all those dedicated to the immunotherapy of cancer can exchange their knowledge and the latest findings about immuno-oncology. The 9th ITOC was held in Munich in September 2022. Major highlights of the 2022 edition included the key note address and life time achievement to Laurence Zitvogel on her contributions on the understanding of the role of microbiota in cancer development and therapy resistance. Her research has paved the way for therapeutic exploitation of the microbiome. Taylor & Francis 2022-12-28 /pmc/articles/PMC9891670/ /pubmed/36576266 http://dx.doi.org/10.1080/21645515.2022.2159706 Text en © 2022 The Author(s). Published with license by Taylor & Francis Group, LLC. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.
spellingShingle Immunotherapeutics – Meeting Report
Dalloul, Iman
Strzalkowski, Thaddäus Jan Clemens
von Bergwelt-Baildon, Michael
Nüssler, Volkmar
Zielinski, Christoph
Kobold, Sebastian
9th Immunotherapy of Cancer conference (ITOC): A meeting report
title 9th Immunotherapy of Cancer conference (ITOC): A meeting report
title_full 9th Immunotherapy of Cancer conference (ITOC): A meeting report
title_fullStr 9th Immunotherapy of Cancer conference (ITOC): A meeting report
title_full_unstemmed 9th Immunotherapy of Cancer conference (ITOC): A meeting report
title_short 9th Immunotherapy of Cancer conference (ITOC): A meeting report
title_sort 9th immunotherapy of cancer conference (itoc): a meeting report
topic Immunotherapeutics – Meeting Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9891670/
https://www.ncbi.nlm.nih.gov/pubmed/36576266
http://dx.doi.org/10.1080/21645515.2022.2159706
work_keys_str_mv AT dallouliman 9thimmunotherapyofcancerconferenceitocameetingreport
AT strzalkowskithaddausjanclemens 9thimmunotherapyofcancerconferenceitocameetingreport
AT vonbergweltbaildonmichael 9thimmunotherapyofcancerconferenceitocameetingreport
AT nusslervolkmar 9thimmunotherapyofcancerconferenceitocameetingreport
AT zielinskichristoph 9thimmunotherapyofcancerconferenceitocameetingreport
AT koboldsebastian 9thimmunotherapyofcancerconferenceitocameetingreport

Ejemplares similares